This Month
Hospitals heading for a ‘fiscal cliff’ without funding fix
Soaring inflation and wages have prompted Catholic Health Australia to warn the survival of some hospitals cannot be guaranteed more than three months out.
Saluda Medical shares sink in worst ASX debut in decades
Former Cochlear boss Catherine Livingstone sits on the board of the US-based company which lost more than 50 pct of its value on the first day of trading.
Doctors concerned Australians are dumping gold-tier health policies
More Australians are abandoning top-level private health insurance as premiums have doubled since 2008.
How the tobacco tax backfired and fuelled a black-market boom
After decades of declining smoking rates, doctors fear the black-market tobacco is creating a new smoking boom, as the government loses a key source of revenue.
Dennis Bastas’ rise from aspiring car designer to $5b pharma king
The son of Greek immigrants signed a mega-deal this year for his pharmaceutical and beauty empire that propelled him to the upper echelons of the Rich List.
Saluda Medical set for $775m ASX debut
With links to Cochlear, the US-based med-tech company has global ambitions for its spinal cord stimulator technology.
NDIS workers submit invoices on serviettes in a system gone ‘wild’
A major NDIS plan management provider says the scheme is bogged down by red tape and needs an urgent overhaul of the payments system.
November
Call for NDIS pricing fix to stop overpayments, fraud
Fraud and overpayment risks in the $50 billion scheme can be reduced if a proposed payment system overhaul is implemented, experts say.
The pharmacist from Fitzroy who amassed a $7b fortune with Chemist Warehouse
The pharmacists who’ve been made rich by following Chemist Warehouse’s Mario Verrocchi call him The Godfather. He’s told them to get back to work.
NDIS providers face $16.5m fines, jail under crackdown
New laws will include harsher penalties and jail time for dodgy providers and stronger powers for regulators to tackle abuse.
Ramsay Health earnings recover in first quarter, Sante decision close
Australia’s largest private hospital operator says EBIT grew 5.8 per cent in the first quarter, but “not where we want them to be”.
Monash IVF rejects $300m takeover bid from Genesis Capital as too low
Shares in the fertility group have fallen more than 40 per cent since mistakes were disclosed earlier this year, prompting the PE-led consortium to swoop.
Chalmers kills $672m Mayne takeover on national interest grounds
The drug manufacturer’s shares plunged 23 per cent on the treasurer’s announcement before being placed in a trading halt. Shareholders are furious.
Mayne shares rally on bid approval hopes as FIRB delays its ruling
In a last-minute decision, the takeovers tribunal has ruled that US healthcare giant Cosette must run Mayne Pharma’s Adelaide factory as part of its bid.
Monash IVF says market share, patients down since embryo mix-ups
Stiff competition and pricing pressure in Victoria has hurt the fertility group’s performance so far this fiscal year.
US pharma ramps up attack on Australia’s ‘discriminatory’ drug pricing
The lobby group representing US drug giants says Australia’s drug pricing policies are harming American innovation and jobs.
‘Japan is safer’: Tokyo’s warning on Cochlear’s China factory
The hearing implant giant says it has no plans to invest in manufacturing in the United States despite Trump’s tariff threats.
CSL plans $2.3b US manufacturing plant as Trump tariffs loom
The global biotech is promising to create American jobs but has not said where its new plasma therapy manufacturing site will be located.
Thousands still flocking to NDIS as costs soar
Almost 14,000 children joined the scheme between July and September this year, more than 66 per cent of total new participants.
The Australian doctor leading a global fight against cerebral palsy
Australia has one of the lowest rates of cerebral palsy in the world, which Nadia Badawi wants to replicate in other countries.